Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Drugs for Metabolic Disorders market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drugs for Metabolic Disordersmarket, defines the market attractiveness level of Drugs for Metabolic Disorders market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drugs for Metabolic Disorders industry, describes the types of Drugs for Metabolic Disorders market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drugs for Metabolic Disorders market and the development prospects and opportunities of Drugs for Metabolic Disorders industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drugs for Metabolic Disorders market in Chapter 13.
By Player:
KOWA
Metsubishi Tanabe Pharma
Fuji yakuhin
Astra Zeneca
Beohrigher Ingelheim
Takeda Pharmaceutical
Novartis
Kythera
Merck
LG Life Science
By Type:
Glycogen Metabolism Disease Drug
Lipid Metabolism Disease Drug
Amino Acid Metabolism Drug
Other
By End-User:
Hospital
Paramary
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drugs for Metabolic Disorders Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drugs for Metabolic Disorders Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drugs for Metabolic Disorders Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drugs for Metabolic Disorders Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drugs for Metabolic Disorders Market Analysis and Outlook to 2022
-
7.1 Global Drugs for Metabolic Disorders Consumption (2017-2022)
-
7.2 United States Drugs for Metabolic Disorders Consumption (2017-2022)
-
7.3 Europe Drugs for Metabolic Disorders Consumption (2017-2022)
-
7.4 China Drugs for Metabolic Disorders Consumption (2017-2022)
-
7.5 Japan Drugs for Metabolic Disorders Consumption (2017-2022)
-
7.6 India Drugs for Metabolic Disorders Consumption (2017-2022)
-
7.7 South Korea Drugs for Metabolic Disorders Consumption (2017-2022)
8 Region and Country-wise Drugs for Metabolic Disorders Market Analysis and Outlook to 2028
-
8.1 Global Drugs for Metabolic Disorders Consumption Forecast (2022-2028)
-
8.2 United States Drugs for Metabolic Disorders Consumption Forecast (2022-2028)
-
8.3 Europe Drugs for Metabolic Disorders Consumption Forecast (2022-2028)
-
8.4 China Drugs for Metabolic Disorders Consumption Forecast (2022-2028)
-
8.5 Japan Drugs for Metabolic Disorders Consumption Forecast (2022-2028)
-
8.6 India Drugs for Metabolic Disorders Consumption Forecast (2022-2028)
-
8.7 South Korea Drugs for Metabolic Disorders Consumption Forecast (2022-2028)
9 Global Drugs for Metabolic Disorders Market Outlook by Types and Applications to 2022
-
9.1 Global Drugs for Metabolic Disorders Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Glycogen Metabolism Disease Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lipid Metabolism Disease Drug Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Amino Acid Metabolism Drug Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Drugs for Metabolic Disorders Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Paramary Consumption and Growth Rate (2017-2022)
10 Global Drugs for Metabolic Disorders Market Outlook by Types and Applications to 2028
-
10.1 Global Drugs for Metabolic Disorders Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Glycogen Metabolism Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lipid Metabolism Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Amino Acid Metabolism Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drugs for Metabolic Disorders Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Paramary Consumption Forecast and Growth Rate (2022-2028)
11 Global Drugs for Metabolic Disorders Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drugs for Metabolic Disorders Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drugs for Metabolic Disorders Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drugs for Metabolic Disorders Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drugs for Metabolic Disorders Market Competitive Analysis
-
14.1 KOWA
-
14.1.1 KOWA Company Details
-
14.1.2 KOWA Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 KOWA Drugs for Metabolic Disorders Product and Service
-
14.2 Metsubishi Tanabe Pharma
-
14.2.1 Metsubishi Tanabe Pharma Company Details
-
14.2.2 Metsubishi Tanabe Pharma Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Metsubishi Tanabe Pharma Drugs for Metabolic Disorders Product and Service
-
14.3 Fuji yakuhin
-
14.3.1 Fuji yakuhin Company Details
-
14.3.2 Fuji yakuhin Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Fuji yakuhin Drugs for Metabolic Disorders Product and Service
-
14.4 Astra Zeneca
-
14.4.1 Astra Zeneca Company Details
-
14.4.2 Astra Zeneca Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Astra Zeneca Drugs for Metabolic Disorders Product and Service
-
14.5 Beohrigher Ingelheim
-
14.5.1 Beohrigher Ingelheim Company Details
-
14.5.2 Beohrigher Ingelheim Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Beohrigher Ingelheim Drugs for Metabolic Disorders Product and Service
-
14.6 Takeda Pharmaceutical
-
14.6.1 Takeda Pharmaceutical Company Details
-
14.6.2 Takeda Pharmaceutical Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Pharmaceutical Drugs for Metabolic Disorders Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Drugs for Metabolic Disorders Product and Service
-
14.8 Kythera
-
14.8.1 Kythera Company Details
-
14.8.2 Kythera Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Kythera Drugs for Metabolic Disorders Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Drugs for Metabolic Disorders Product and Service
-
14.10 LG Life Science
-
14.10.1 LG Life Science Company Details
-
14.10.2 LG Life Science Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 LG Life Science Drugs for Metabolic Disorders Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drugs for Metabolic Disorders
-
Figure Drugs for Metabolic Disorders Picture
-
Table Global Drugs for Metabolic Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Metabolic Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Metabolic Disorders Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drugs for Metabolic Disorders Consumption by Country (2017-2022)
-
Figure United States Drugs for Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Table Europe Drugs for Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure China Drugs for Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Japan Drugs for Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure India Drugs for Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drugs for Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Metabolic Disorders Consumption Forecast by Country (2022-2028)
-
Figure United States Drugs for Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drugs for Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drugs for Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drugs for Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drugs for Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drugs for Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glycogen Metabolism Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Lipid Metabolism Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Amino Acid Metabolism Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Paramary Consumption and Growth Rate (2017-2022)
-
Figure Global Glycogen Metabolism Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lipid Metabolism Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amino Acid Metabolism Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Paramary Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drugs for Metabolic Disorders Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drugs for Metabolic Disorders Export by Region (Top 5 Countries) (2017-2028)
-
Table KOWA (Foundation Year, Company Profile and etc.)
-
Table KOWA Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table KOWA Drugs for Metabolic Disorders Product and Service
-
Table Metsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)
-
Table Metsubishi Tanabe Pharma Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Metsubishi Tanabe Pharma Drugs for Metabolic Disorders Product and Service
-
Table Fuji yakuhin (Foundation Year, Company Profile and etc.)
-
Table Fuji yakuhin Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fuji yakuhin Drugs for Metabolic Disorders Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca Drugs for Metabolic Disorders Product and Service
-
Table Beohrigher Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Beohrigher Ingelheim Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beohrigher Ingelheim Drugs for Metabolic Disorders Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Drugs for Metabolic Disorders Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Drugs for Metabolic Disorders Product and Service
-
Table Kythera (Foundation Year, Company Profile and etc.)
-
Table Kythera Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kythera Drugs for Metabolic Disorders Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Drugs for Metabolic Disorders Product and Service
-
Table LG Life Science (Foundation Year, Company Profile and etc.)
-
Table LG Life Science Drugs for Metabolic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table LG Life Science Drugs for Metabolic Disorders Product and Service
-
